摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-乙酰氧基-6-(2,3-二溴丙基)-4,8-二甲基香豆素 | 3993-46-2

中文名称
7-乙酰氧基-6-(2,3-二溴丙基)-4,8-二甲基香豆素
中文别名
——
英文名称
4,8-dimethyl-6-(2,3-dibromopropyl)-7-acetoxycoumarin
英文别名
7-acetoxy-6-(2,3-dibromopropyl)-4,8-dimethylcoumarin;7-Acetoxy-6-(2',3'-dibrompropyl)-4,8-dimethyl-cumarin;6-(2,3-dibromopropyl)-4,8-dimethyl-7-acetoxycoumarin;[6-(2,3-dibromopropyl)-4,8-dimethyl-2-oxochromen-7-yl] acetate
7-乙酰氧基-6-(2,3-二溴丙基)-4,8-二甲基香豆素化学式
CAS
3993-46-2
化学式
C16H16Br2O4
mdl
——
分子量
432.109
InChiKey
FCDMHZRMXOOYRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    146-148 °C(lit.)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.375
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2932209090

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-乙酰氧基-6-(2,3-二溴丙基)-4,8-二甲基香豆素 在 sodium tetrahydroborate 、 硝酸溶剂黄146 作用下, 以 乙二醇二甲醚 为溶剂, 反应 17.0h, 生成 3-nitro-4,8-dimethyl-5'-bromomethyl-4',5'-dihydropsoralen
    参考文献:
    名称:
    3-取代的5'-(N-吡啶鎓甲基)-4',5'-二氢补骨脂素的合成方法
    摘要:
    描述了3-取代-5'-(N-吡啶鎓甲基)-4',5'-二氢补骨脂素的新的合成方法。提出的新途径利用适当取代的香豆素和4',5'-二氢补骨脂素。建议的化合物代表补骨脂素紫外线辐射治疗的潜在治疗剂。
    DOI:
    10.1002/jhet.5570370106
点击查看最新优质反应信息

文献信息

  • AMINO-AND MERCURIO-SUBSTITUTED 4', 5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF
    申请人:BUCKMAN LABORATORIES INTERNATIONAL, INC.
    公开号:EP1133498A2
    公开(公告)日:2001-09-19
  • US6255324B1
    申请人:——
    公开号:US6255324B1
    公开(公告)日:2001-07-03
  • [EN] AMINO- AND MERCURIO-SUBSTITUTED 4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF<br/>[FR] 4',5'-DIHYDROPSORALENES AMINO ET MERCURIO SUBSTITUES ET LEURS UTILISATIONS THERAPEUTIQUES
    申请人:BUCKMAN LABOR INC
    公开号:WO2000031081A2
    公开(公告)日:2000-06-02
    5'- substituted, 4', 5'- dihydropsoralen compounds (5) bearing tertiary amines (and salts thereof), quaternary ammonium moieties or organomercurial moieties are described. Also described are 2- substituted mercurimethyl -2-3- dihydro -benzofurans of formula (7). Also reported are versatile direct syntheses through a hitherto unknown compounds such as 3-R-4, 8-dimethyl -4',5'-dihydro -5'-bromomethylpsoralen or a 3-R-4, 8-dimethyl-4, 5'-dihydro- 5'-iodomethylpsoralen to prepare a structurally diverse array of partially reduced psoralens and benzofurans. The presence of a permanent ammonium charge in these psoralens precludes membrane passage and the mono-unsaturation precludes the cross linking of nuclear DNA, thereby minimizing the mutagenic/carcinogenic side effects long associated with psoralen-derived therapies. The presence of a mercury functionality provides a reactive cell-binding group on these psoralens with unique cytotoxicity without light activation and an enhancement of cytotoxicity activity upon light activation. The invention also relates to these partially reduced and quaternized psoralens, amino-substituted psoralens, and mercurio psoralens display impressive pharmacology against PAM 212 keratinocytes, a model cell line employed as a test system to indicate epidermal cytotoxicity and cancer. The compounds of the invention also have antimicrobicidal activity useful in pharmacologic agents for mammals (e.g. the treatment of tuberculosis) as well as in controlling the growth of microorganisms on substrates and in aqueous systems.
  • Synthetic approaches to 3-substituted-5′-(N-pyridiniummethyl)-4′,5′-dihydropsoralen
    作者:Ivan Jabin、Ned D. Heindel、Robert D. Rapp、Jeffrey D. Laskin
    DOI:10.1002/jhet.5570370106
    日期:2000.1
    New synthetic approaches to 3-substituted-5′-(N-pyridiniummethyl)-4′,5-dihydropsoralens are described. The novel pathways presented utilize appropriately substituted coumarins and 4′,5-dihydropsoralens. The compounds proposed represent potential therapeutic agents for psoralen uv radiation treatment.
    描述了3-取代-5'-(N-吡啶鎓甲基)-4',5'-二氢补骨脂素的新的合成方法。提出的新途径利用适当取代的香豆素和4',5'-二氢补骨脂素。建议的化合物代表补骨脂素紫外线辐射治疗的潜在治疗剂。
查看更多